AMRI today announced it received a 10-year federal contract award from the National Institutes of Health for drug development and manufacturing services. This NIH/National Institute of Neurological Disorders and Stroke award will support NIH's Drug Manufacturing and Formulation Program (DMFP), which is a component of the Blueprint Neurotherapeutics Network (BPN).
from The Medical News http://ift.tt/15pg3Pa
from The Medical News http://ift.tt/15pg3Pa
No comments:
Post a Comment